Investing
Top Active Trader Alert Stocks (AGNC, ASML, LULU, TEVA)
Published:
Last Updated:
Active traders and day traders have many stocks to choose from this Thursday morning. We are tracking news and moves in shares of American Capital Agency Corp. (NASDAQ: AGNC), ASML Holding (NASDAQ: ASML), Lululemon Athletica (NASDAQ: LULU), and Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA).
American Capital Agency Corp. (NASDAQ: AGNC) is down 6% to $27.69, relative to a 52-week range of $23.61-$29.02. The company recently announced an offering of 8 million shares of common stock.
ASML Holding (NASDAQ: ASML) is up nearly 6% to $37.18, relative to a 52-week range of $26.08-$36.34. The company announced an improved 3Q bookings outlook.
Lululemon Athletica (NASDAQ: LULU) is up more than 10% to $61.42, relative to a 52-week range of $25.75-$56.12. The Company had positive 2Q report.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is up 6.43% on heavy volume to $52.46, relative to a 52-week range of $46.99-$64.95. The company had announced successful phase III trials of one of its multiple sclerosis drugs.
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.